UNS
Click for more information
0.00% 0.5¢ unilife corporation

With Amgen having success in having biosimilars approved by fta,...

  1. ChristopherC
    4,789 Posts.
    lightbulb Created with Sketch. 513
    clock Created with Sketch.
    26/01/16
    11:20
    Post #: 16869489
    With Amgen having success in having biosimilars approved by fta, i suggest this may further future developments with other biosimilars that with an agreement with UNS may see their technology used to deliver these down the track when being approved by fta, and thus lock in a substantial future revenue stream.This is my take on this , has anyone got a different angle?
    UNS Price at posting: 21.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.